Waight et al. further confirmed a marked increase in splenic CD11b+Gr-1+ cells of 4T1 tumor-bearing mice in response to granulocyte colony-stimulating factor (G-CSF) [61]. The gene discussed is CSF3; the disease is neoplasm.